Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 6/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14934959 | 0.92 | SMN1; SMN2 (0.44) | MAPTALDH1A1RAB9AGAAALOX5 | |
| SCHEMBL8374205 | 0.90 | ALOX5 (0.54) | MAPTALDH1A1ALOX5MEN1KMT2A | |
| SCHEMBL19311948 | 0.89 | TSHR (0.49) | MAPTALDH1A1RAB9AGAAALOX5 | |
| SCHEMBL8379789 | 0.87 | CASR (0.51) | MAPTALDH1A1RAB9AGAAALOX5 | |
| SCHEMBL8374111 | 0.84 | CASR (0.46) | MAPTALDH1A1RAB9AALOX5MEN1 | |
| SCHEMBL6864033 | 0.81 | GAA (0.47) | MAPTALDH1A1RAB9AGAAALOX5 | |
| SCHEMBL4579151 | 0.81 | MAPT (0.47) | MAPTALDH1A1RAB9AGAAALOX5 | |
| SCHEMBL28060524 | 0.79 | ICMT (0.56) | MAPTALDH1A1RAB9AALOX5MEN1 | |
| SCHEMBL3403490 | 0.78 | NQO2 (0.40) | ALDH1A1HTTHPGD | |
| SCHEMBL31148959 | 0.78 | SMN1; SMN2 (0.57) | MAPTALDH1A1GAAALOX5MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2773610-B1 | IODINATION PROCESS FOR THE PREPARATION OF 3,5-DISUBSTITUTED-2,4,6-TRIIODO AROMATIC AMINES COMPOUNDS | IMAX DIAGNOSTIC IMAGING HOLDING LTD (CN) | 2017-09-06 | — | — | EP | disclosed |
| US-9382194-B2 | Iodination process for the preparation of 3, 5-disubstituted-2, 4, 6-triiodo aromatic amines compounds | IMAX DIAGNOSTIC IMAGING HOLDING LIMITED (CN) | 2016-07-05 | — | — | US | disclosed |
| US-9382194-B2 | Iodination process for the preparation of 3, 5-disubstituted-2, 4, 6-triiodo aromatic amines compounds | IMAX DIAGNOSTIC IMAGING HOLDING LIMITED (CN) | 2016-07-05 | — | — | US | disclosed |
| US-20150025275-A1 | Iodination Process for the Preparation of 3, 5-Disubstituted-2, 4, 6-Triiodo Aromatic Amines Compounds | IMAX DIAGNOSTIC IMAGING HOLDING LIMITED (CN) | 2015-01-22 | — | — | US | disclosed |
| US-20150025275-A1 | Iodination Process for the Preparation of 3, 5-Disubstituted-2, 4, 6-Triiodo Aromatic Amines Compounds | IMAX DIAGNOSTIC IMAGING HOLDING LIMITED (CN) | 2015-01-22 | — | — | US | disclosed |
| EP-2773610-A1 | IODINATION PROCESS FOR THE PREPARATION OF 3,5-DISUBSTITUTED-2,4,6-TRIIODO AROMATIC AMINES COMPOUNDS | iMAX Diagnostic Imaging Holding Limited (CN) | 2014-09-10 | — | — | EP | disclosed |
| WO-2013063737-A1 | IODINATION PROCESS FOR THE PREPARATION OF 3,5-DISUBSTITUTED-2,4,6-TRIIODO AROMATIC AMINES COMPOUNDS | HOVIONE CHINA HOLDING LIMITED (CN) | 2013-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150025275-A1 | Iodination Process for the Preparation of 3, 5-Disubstituted-2, 4, 6-Triiodo Aromatic Amines Compounds | TPO, AOC2, INSR | MAPT 3310/4885ALDH1A1 2858/4885RAB9A 1137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.